Cargando…

Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles

Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different surfactants including Aerosol OT and Tween 80. The nanoparticles were characterized using t...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirshahi, Vahid, Shamsipour, Fereshteh, Zarnani, Amir Hassan, Verdi, Javad, Saber, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452043/
https://www.ncbi.nlm.nih.gov/pubmed/26069499
http://dx.doi.org/10.1007/s12645-013-0035-6
_version_ 1782374239318310912
author Shirshahi, Vahid
Shamsipour, Fereshteh
Zarnani, Amir Hassan
Verdi, Javad
Saber, Reza
author_facet Shirshahi, Vahid
Shamsipour, Fereshteh
Zarnani, Amir Hassan
Verdi, Javad
Saber, Reza
author_sort Shirshahi, Vahid
collection PubMed
description Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different surfactants including Aerosol OT and Tween 80. The nanoparticles were characterized using transmission electron microscopy, dynamic light scattering, and zeta potential analysis. Our results revealed that the type of surfactant molecules has a dramatic impact on the size and size distribution range, surface charge, and surface functionalization of the nanoparticles. The particles fabricated using Tween 80 had very smaller size with narrow size distribution and very lower amount of zeta potential. For specific delivery of functionalized nanoparticles to breast cancer cell line SKBR3, overexpressing human epidermal growth factor receptor 2 (HER2), both dye-doped nanoparticles fabricated with Aerosol OT or Tween 80, was conjugated to Herceptin. In vitro studies using fluorescent microscopy demonstrated that the surfactant used for preparation of the nanoparticles can affect the uptake of the particles by cells. The dye-doped functionalized ORMOSIL nanoparticles prepared with Aerosol OT showed better efficiency in the process of active targeting of HER2 receptor. Herceptin-functionalized ORMOSIL nanoparticles can be used for differentiation of HER2-positive from HER2-negative breast cancer cells or specific delivery of therapeutic and diagnostic agents and also other nanoparticles such as magnetic nanoparticles and quantum dots to breast cancer cells. [Figure: see text]
format Online
Article
Text
id pubmed-4452043
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-44520432015-06-09 Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles Shirshahi, Vahid Shamsipour, Fereshteh Zarnani, Amir Hassan Verdi, Javad Saber, Reza Cancer Nanotechnol Original Paper Normal micelle microemulsion method was utilized for fabrication of organically modified silica (ORMOSIL) nanoparticles. The void and dye-doped nanoparticles were synthesized in nonpolar core of two different surfactants including Aerosol OT and Tween 80. The nanoparticles were characterized using transmission electron microscopy, dynamic light scattering, and zeta potential analysis. Our results revealed that the type of surfactant molecules has a dramatic impact on the size and size distribution range, surface charge, and surface functionalization of the nanoparticles. The particles fabricated using Tween 80 had very smaller size with narrow size distribution and very lower amount of zeta potential. For specific delivery of functionalized nanoparticles to breast cancer cell line SKBR3, overexpressing human epidermal growth factor receptor 2 (HER2), both dye-doped nanoparticles fabricated with Aerosol OT or Tween 80, was conjugated to Herceptin. In vitro studies using fluorescent microscopy demonstrated that the surfactant used for preparation of the nanoparticles can affect the uptake of the particles by cells. The dye-doped functionalized ORMOSIL nanoparticles prepared with Aerosol OT showed better efficiency in the process of active targeting of HER2 receptor. Herceptin-functionalized ORMOSIL nanoparticles can be used for differentiation of HER2-positive from HER2-negative breast cancer cells or specific delivery of therapeutic and diagnostic agents and also other nanoparticles such as magnetic nanoparticles and quantum dots to breast cancer cells. [Figure: see text] Springer Vienna 2013-03-27 2013 /pmc/articles/PMC4452043/ /pubmed/26069499 http://dx.doi.org/10.1007/s12645-013-0035-6 Text en © Springer-Verlag Wien 2013
spellingShingle Original Paper
Shirshahi, Vahid
Shamsipour, Fereshteh
Zarnani, Amir Hassan
Verdi, Javad
Saber, Reza
Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
title Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
title_full Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
title_fullStr Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
title_full_unstemmed Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
title_short Active targeting of HER2-positive breast cancer cells by Herceptin-functionalized organically modified silica nanoparticles
title_sort active targeting of her2-positive breast cancer cells by herceptin-functionalized organically modified silica nanoparticles
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452043/
https://www.ncbi.nlm.nih.gov/pubmed/26069499
http://dx.doi.org/10.1007/s12645-013-0035-6
work_keys_str_mv AT shirshahivahid activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles
AT shamsipourfereshteh activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles
AT zarnaniamirhassan activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles
AT verdijavad activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles
AT saberreza activetargetingofher2positivebreastcancercellsbyherceptinfunctionalizedorganicallymodifiedsilicananoparticles